Tryptamine Therapeutics's total assets for Q4 2024 were AU$6.66M, an increase of 25.83% from the previous quarter. AU:ENP total liabilities were AU$699.17K for the fiscal quarter, a -34.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.